Doxorubicin aglycone
- Level
- Commodity
- Parent
- 51281800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281817This classification denotes a doxorubicin preparation with the molecular formula C21H18O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X023T6C35L, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8s,10s)-, but more generally known as doxorubicin aglycone, which bears US NIH Compound Identifier 72401. European Medicines Agency schedules doxorubicin aglycone or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06391MIG. Most nations, for tariff purposes, schedule doxorubicin aglycone under HS 29419000. SMILES: COC1CCCC2C1C(=O)C3C(C(C4C(C3O)[C@H](C[C@@](C4)(C(=O)CO)O)O)O)C2=O.
Same parent
Under 51281800 · 24Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.